Skip to main content

Advertisement

Log in

Thymoma with Concomitant Pure Red Cell Aplasia, Good’s Syndrome and Myasthenia Gravis Responding to Rituximab

  • Case Report
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

Abstract

Thymomas are often associated with a variety of autoimmune diseases, mostly myasthenia gravis. The association of thymomas with both pure red cell aplasia (PRCA) and Good’s syndrome is exceedingly rare. To the best of our knowledge, the combination of a thymoma with manifestations of myasthenia gravis, PRCA, and Good’s syndrome, as in our case herein, has not been described before in the medical literature. We present a 90-year-old man initially diagnosed with an asymptomatic thymoma. Later, he developed generalized muscle weakness and was found to have severe anemia. He was diagnosed with PRCA, myasthenia gravis and Good’s syndrome. He responded to rituximab with restoration of bone marrow erythroid maturation and stabilization of red blood cell counts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Rosai J, Sobin LH (1999) Histological typing of tumours of the thymus. Springer, New York, p 1–16

  2. Kondo K, Yoshizawa K, Tsuyuguchi M, Kimura S, Sumitomo M, Morita J, Miyoshi T, Sakiyama S, Mukai K, Monden Y (2004) WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg 77:1183–1188

    Article  PubMed  Google Scholar 

  3. Muller-Hermelink HK, Marx A (2000) Thymoma. Curr Opin Oncol 12:426–433

    Article  CAS  PubMed  Google Scholar 

  4. Shelly S, Agmon-Levin N, Altman A, Shoenfeld Y (2011) Thymoma and autoimmunity. Cell Mol Immunol 8:199–202

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Hoffacker V, Schultz A, Tiesinga JJ, Gold R, Schalke B, Nix W, Kiefer R, Müller-Hermelink HK, Marx A (2000) Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease. Blood 96:3872–3879

    CAS  PubMed  Google Scholar 

  6. Lin CS, Yu YB, Hsu HS, Chou TY, Hsu WH, Huang BS (2009) Pure red cell aplasia and hypogammaglobulinemia in a patient with thymoma. J Chin Med Assoc 72:34–38

    Article  PubMed  Google Scholar 

  7. Chen J, Yang Y, Zhu D, Chen G, Wei S, Qiu X, Zhou Q (2011) Thymoma with pure red cell aplasia and Good’s syndrome. Ann Thorac Surg 91:1620–1622

    Article  PubMed  Google Scholar 

  8. van der Marel J, Pahlplatz PV, Steup WH, Hendriks ER (2007) Thymoma with paraneoplastic syndromes, Good’s syndrome, and pure red cell aplasia. J Thorac Oncol 2:325–326

    Article  PubMed  Google Scholar 

  9. Shiraishi J, Tsugata M, Masuda R, Mori Y, Suzuki K, Takemura T (2008) Type AB thymoma accompanied by pure red cell aplasia and Good syndrome with CMV infection of tumor cells. Pathol Int 58:489–493

    Article  PubMed  Google Scholar 

  10. Zeok JV, Todd EP, Dillon M, DeSimone P, Utley JR (1979) The role of thymectomy in red cell aplasia. Ann Thorac Surg 28:257–260

    Article  CAS  PubMed  Google Scholar 

  11. Kelleher P, Misbah S (2003) What is Good’s syndrome? Immunological abnormalities in patients with thymoma. J Clin Pathol 56:12–16

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Mamiya S, Itoh T, Miura AB (1997) Acquired pure red cell aplasia in Japan. Eur J Haematol 59:199–205

    Article  CAS  PubMed  Google Scholar 

  13. Thompson CA, Steensma DP (2006) Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience. Br J Haematol 135:405–407

    Article  PubMed  Google Scholar 

  14. Garcia Vela JA, Monteserin MC, Ona F, Barea LM, Lastra A, Perez V (1993) Cyclosporine A used as a single drug in the treatment of pure red cell aplasia associated with thymoma. Am J Hematol 42:238–239

    Article  CAS  PubMed  Google Scholar 

  15. Pantelidou D, Tsatalas C, Margaritis D, Kaloutsi V, Spanoudakis E, Bourikas G (2004) Anti-CD20 monoclonal antibody rituximab for the treatment of B-cell chronic lymphocytic leukemia-associated pure red cell aplasia. Hematol J 5:546–547

    Article  CAS  PubMed  Google Scholar 

  16. Narra K, Borghaei H, Al-Saleem T, Hoglund M, Smith MR (2006) Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature. Leuk Res 30:109–114

    Article  CAS  PubMed  Google Scholar 

  17. Dungarwalla M, Marsh JC, Tooze JA, Lucas G, Ouwehand W, Pettengell R, Dearden CE, Gordon Smith EC, Elebute MO (2007) Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology. Ann Hematol 86:191–197

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosure

Institutional review board/Ethics committee approval for case report publication is not needed as per our hospital regulations.

Conflict of interest

All authors declare they do not have any competing interests to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ziad M. Salem.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antar, A.I., Otrock, Z.K., Kharfan-Dabaja, M.A. et al. Thymoma with Concomitant Pure Red Cell Aplasia, Good’s Syndrome and Myasthenia Gravis Responding to Rituximab. Indian J Hematol Blood Transfus 32 (Suppl 1), 219–222 (2016). https://doi.org/10.1007/s12288-014-0478-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-014-0478-x

Keywords

Navigation